Relay Therapeutics Inc (RLAY)

Cost of Revenue

$68.99M

TTM · Period ending: · USD

RLAY logo

RLAY Cost of Revenue

Latest reported$68.99M
RLAY TTM Cost of Revenue ($0.00 → $68.99M)
High-resolution chart · PNG

RLAY cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Relay Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
68,992,000
130,464,000
129,960,000
193,788,000
202,518,000
233,038,000
315,441,000
324,879,000
329,754,000
325,963,000
326,387,000
316,449,000
301,855,000
274,165,000
243,005,000
230,158,000
207,413,000
192,049,000
171,004,000
120,836,000
76,681,000
31,534,000
912,000
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.